Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | trypanothione reductase, putative | 0.0016 | 0.0325 | 0.0158 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Echinococcus granulosus | serine protein kinase ATM | 0.0026 | 0.1014 | 0.2198 |
Treponema pallidum | NADH oxidase | 0.0016 | 0.0325 | 0.5 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0059 | 0.3461 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0019 | 0.0506 | 0.1433 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0016 | 0.0325 | 0.1149 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0019 | 0.0506 | 0.1789 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0019 | 0.0506 | 0.087 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.005 | 0.2825 | 0.8912 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0019 | 0.0506 | 0.087 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0106 | 0.6909 | 0.8837 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0118 | 0.7776 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0106 | 0.6909 | 0.8837 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0106 | 0.6909 | 0.8837 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0016 | 0.0284 | 0.0897 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.005 | 0.2825 | 0.7974 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.2825 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0022 | 0.0752 | 0.184 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0325 | 0.0158 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0019 | 0.0506 | 0.087 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0026 | 0.1014 | 0.3588 |
Leishmania major | phosphatidylinositol 3-related kinase, putative | 0.0019 | 0.0506 | 0.0696 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0325 | 0.0126 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0325 | 0.0158 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.2825 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0019 | 0.0506 | 0.0187 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.005 | 0.2825 | 1 |
Giardia lamblia | Kinase, CMGC MAPK | 0.005 | 0.2825 | 1 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0059 | 0.3461 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0019 | 0.0506 | 0.1789 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0019 | 0.0506 | 0.1789 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0059 | 0.3461 | 1 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0016 | 0.0325 | 0.1149 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0059 | 0.3461 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0752 | 0.2372 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0019 | 0.0506 | 0.1789 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.005 | 0.2825 | 0.7974 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0026 | 0.1027 | 0.3239 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0019 | 0.0506 | 0.1595 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0325 | 0.0158 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0118 | 0.7776 | 1 |
Echinococcus granulosus | mitogen activated protein kinase | 0.005 | 0.2825 | 0.7974 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0019 | 0.0506 | 0.0577 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0106 | 0.6909 | 0.8837 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0047 | 0.2549 | 0.7092 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0019 | 0.0506 | 0.0577 |
Toxoplasma gondii | thioredoxin reductase | 0.0047 | 0.2549 | 0.9021 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0106 | 0.6909 | 0.8837 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0325 | 0.0158 |
Plasmodium falciparum | thioredoxin reductase | 0.0047 | 0.2549 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0047 | 0.2549 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.005 | 0.2825 | 1 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0059 | 0.3461 | 1 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0016 | 0.0325 | 0.0158 |
Brugia malayi | glutathione reductase | 0.0047 | 0.2549 | 0.7356 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0016 | 0.0325 | 0.1149 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0325 | 0.0158 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0016 | 0.0325 | 0.1149 |
Brugia malayi | Thioredoxin reductase | 0.0047 | 0.2549 | 0.7356 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0047 | 0.2549 | 0.8911 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Toxoplasma gondii | FATC domain-containing protein | 0.0026 | 0.1014 | 0.3588 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0019 | 0.0506 | 0.1433 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0055 | 0.317 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.005 | 0.2825 | 1 |
Brugia malayi | MAP kinase sur-1 | 0.005 | 0.2825 | 0.8158 |
Trypanosoma brucei | protein kinase, putative | 0.005 | 0.2825 | 1 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0026 | 0.1014 | 0.2198 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0016 | 0.0325 | 0.0158 |
Schistosoma mansoni | serine/threonine protein kinase | 0.005 | 0.2825 | 0.2585 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0019 | 0.0506 | 0.0696 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0325 | 0.0126 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0016 | 0.0325 | 0.0126 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0019 | 0.0506 | 0.087 |
Leishmania major | trypanothione reductase | 0.0047 | 0.2549 | 0.7129 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0016 | 0.0325 | 0.1149 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0047 | 0.2549 | 0.7092 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0019 | 0.0506 | 0.0577 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0016 | 0.0284 | 0.0897 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.005 | 0.2825 | 0.8 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0026 | 0.1014 | 0.2906 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0016 | 0.0325 | 0.0126 |
Giardia lamblia | GTOR | 0.0019 | 0.0506 | 0.0724 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0106 | 0.6909 | 0.8837 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0016 | 0.0325 | 0.5 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0019 | 0.0508 | 0.0881 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0016 | 0.0325 | 0.0908 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Leishmania major | phosphatidylinositol 3-kinase, putative | 0.0019 | 0.0506 | 0.0696 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0019 | 0.0506 | 0.1789 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0019 | 0.0506 | 0.0696 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0059 | 0.3461 | 0.4209 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0059 | 0.3461 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0026 | 0.1014 | 0.287 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.005 | 0.2825 | 0.8 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0016 | 0.0325 | 0.1149 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0016 | 0.0325 | 0.1149 |
Plasmodium vivax | glutathione reductase, putative | 0.0047 | 0.2549 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0118 | 0.7776 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0016 | 0.0284 | 0.0897 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.005 | 0.2825 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0016 | 0.0325 | 0.0126 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0019 | 0.0506 | 0.1789 |
Trypanosoma brucei | trypanothione reductase | 0.0047 | 0.2549 | 0.9021 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0047 | 0.2549 | 0.2985 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0019 | 0.0506 | 0.087 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0019 | 0.0506 | 0.1595 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0026 | 0.1014 | 0.0712 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 0.1014 | 0.3588 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0047 | 0.2549 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0016 | 0.0325 | 0.0126 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0019 | 0.0506 | 0.0696 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0118 | 0.7776 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.005 | 0.2825 | 0.7974 |
Brugia malayi | Cytochrome P450 family protein | 0.0016 | 0.0284 | 0.0792 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0325 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.005 | 0.2825 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0047 | 0.2549 | 0.804 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.005 | 0.2825 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0016 | 0.0284 | 0.0792 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0325 | 0.5 |
Leishmania major | phosphatidylinositol kinase related protein, putative | 0.0019 | 0.0508 | 0.0704 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.2825 | 1 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0019 | 0.0506 | 0.0187 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0047 | 0.2549 | 0.804 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.2825 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0026 | 0.1027 | 0.2944 |
Entamoeba histolytica | hypothetical protein | 0.0026 | 0.1014 | 1 |
Trypanosoma brucei | cytochrome P450, putative | 0.0016 | 0.0284 | 0.1007 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0019 | 0.0506 | 0.0577 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0016 | 0.0325 | 0.0158 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0016 | 0.0325 | 0.0126 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0016 | 0.0325 | 0.1149 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.0506 | 0.1789 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0059 | 0.3461 | 0.3241 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.